Imatinib mesylate treatment of nephrogenic systemic fibrosis. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

Adverse clinical outco

Imatinib mesylate trea

See All (2) pages

Contact Us
If you have any questions or feedback please contact us.

Imatinib mesylate treatment of nephrogenic systemic fibrosis.

Kay J, High WA. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 2008 Aug; 58(8):2543-8.

View in: PubMed

subject areas

authors with profiles

Whitney A High

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)